[Cleveland Brown]

^ Hopefully it is from northern European fetuses, preferably Scandinavian. Diabetics at peer banks would rather go into a coma than use insulin from PIIGS fetuses, or god forbid anywhere outside of Europe, Japan, and select areas in north America.

Also, the firm has been thinking about starting a trade in insulin futures (much like crude oil futures) due to the rise of obesity and the resulting diabetes. Buckeye should start hedging his insulin needs now as forecasts predict surging insulin demand after Holiday Season 2012 and decreased supplies due to insulin manufacturer consolidations. Obviously, the consolidations were necessary due to investor dissatisfaction that each insulin dose only earns pharmaceutical companies $1 in profit per dose while heart medications earn, on average, $5 per dose. The era of economically insane and unfairly cheap diabetic medicines is over, as it should be.